Jacobson Center for Clinical & Translational Research

Main Menu


Additional Information


Contact Us

HIV Studies

Study Title:  A Study Evaluating the Effect of Pitavastatin to Prevent Cardiovasular Events in HIV-1 Infected Individuals (REPRIEVE).  (Identifier: NCT02344290)

Study Purpose:  People infected with HIV are at risk for cardiovascular disease (CVD). This study will evaluate the use of pitavastatin to reduce the risk of CVD in adults infected with HIV who are on antiretroviral therapy (ART).

Principal Investigator: Joan Duggan, M.D.

Study Coordinator: Nicole Amadio, RN for more information, please call 419-383-4387.

Last Updated: 6/20/16